» Articles » PMID: 27317411

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework

Overview
Journal AIDS Behav
Date 2016 Jun 19
PMID 27317411
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Placebo-controlled trials of pre-exposure prophylaxis (PrEP) have reported challenges with study-product uptake and use, with the greatest challenges reported in studies with young women in sub-Saharan Africa. We conducted a qualitative sub-study to explore experiences with open-label PrEP among young women in Cape Town, South Africa participating in HTPN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT). HPTN 067/ADAPT provided open label oral FTC/TDF PrEP to young women in Cape Town, South Africa who were randomized to daily and non-daily PrEP regimens. Following completion of study participation, women were invited into a qualitative sub-study including focus groups and in-depth interviews. Interviews and groups followed a semi-structured guide, were recorded, transcribed, and translated to English from isiXhosa, and coded using framework analysis. Sixty of the 179 women enrolled in HPTN 067/ADAPT participated in either a focus group (six groups for a total of 42 participants) or an in-depth interview (n = 18). This sample of mostly young, unmarried women identified facilitators of and barriers to PrEP use, as well as factors influencing study participation. Cross-cutting themes characterizing discourse suggested that women placed high value on contributing to the well-being of one's community (Ubuntu), experienced a degree of skepticism towards PrEP and the study more generally, and reported a wide range of approaches towards PrEP (ranging from active avoidance to high levels of persistence and adherence). A Mutuality Framework is proposed that identifies four dynamics (distrust, uncertainty, alignment, and mutuality) that represent distinct interactions between self, community and study and serve to contextualize women's experiences. Implications for better understanding PrEP use, and non-use, and intervention opportunities are discussed. In this sample of women, PrEP use in the context of an open-label research trial was heavily influenced by underlying beliefs about safety, reciprocity of contributions to community, and trust in transparency and integrity of the research. Greater attention to factors positioning women in the different dynamics of the proposed Mutuality Framework could direct intervention approaches in clinical trials, as well as open-label PrEP scale-up.

Citing Articles

Facilitators and Barriers to Pre-Exposure Prophylaxis Uptake Willingness for Full-Service Sex Workers: A Social-Ecological Approach.

Ramos S, Du Bois S Sociol Inq. 2025; 94(4):890-909.

PMID: 39831188 PMC: 11737633. DOI: 10.1111/soin.12589.


HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review.

Makoni W, Lorenzetti L, Mancuso N, Luecke E, Dinh N, Deshpande A AIDS Behav. 2024; 29(1):257-293.

PMID: 39422786 DOI: 10.1007/s10461-024-04529-2.


Applying CFIR to assess multi-level barriers to PrEP delivery in rural South Africa: Processes, gaps and opportunities for service delivery of current and future PrEP modalities.

Baron D, Leslie H, Mabetha D, Becker N, Kahn K, Lippman S Soc Sci Med. 2024; 361:117370.

PMID: 39366151 PMC: 11554290. DOI: 10.1016/j.socscimed.2024.117370.


We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.

Atujuna M, Williams K, Roberts S, Young A, Browne E, Mangxilana N PLoS One. 2024; 19(8):e0308577.

PMID: 39208281 PMC: 11361692. DOI: 10.1371/journal.pone.0308577.


"Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.

Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce I BMC Womens Health. 2024; 24(1):462.

PMID: 39174929 PMC: 11342472. DOI: 10.1186/s12905-024-03269-8.


References
1.
Mays N, Pope C . Qualitative research: Observational methods in health care settings. BMJ. 1995; 311(6998):182-4. PMC: 2550229. DOI: 10.1136/bmj.311.6998.182. View

2.
Penner L, Hagiwara N, Eggly S, Gaertner S, Albrecht T, Dovidio J . Racial Healthcare Disparities: A Social Psychological Analysis. Eur Rev Soc Psychol. 2014; 24(1):70-122. PMC: 4151477. DOI: 10.1080/10463283.2013.840973. View

3.
Cooper L, Hill M, Powe N . Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002; 17(6):477-86. PMC: 1495065. DOI: 10.1046/j.1525-1497.2002.10633.x. View

4.
van der Straten A, Montgomery E, Musara P, Etima J, Naidoo S, Laborde N . Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015; 29(16):2161-71. PMC: 4638164. DOI: 10.1097/QAD.0000000000000801. View

5.
Van der Elst E, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P . High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2012; 17(6):2162-72. PMC: 3690654. DOI: 10.1007/s10461-012-0317-8. View